Inspira Technologies Oxy B.H.N. Ltd. (IINNW) 股票分析

公司概述

Inspira Technologies Oxy B.H.N. Ltd. operates as a specialty medical device company focused on the research, development, manufacturing, and marketing of proprietary life support technologies designed for the treatment of acute respiratory failure within the Israeli market. Although specific sector and industry classifications are not publicly listed for the entity, its business model is centered on providing critical medical solutions such as the INSPIRA ART100 life support system used in procurement contexts. The company maintains a relatively small operational footprint with a workforce of 34 employees, while its market capitalization and annual revenue figures are not disclosed in available public data. The absence of disclosed market cap and revenue figures suggests that the company operates on a micro-cap scale or utilizes an alternative reporting structure that obscures its total enterprise value from standard valuation metrics.

财务健康

The company reported a trailing twelve-month revenue of $289,000, yet it posted a net income of -$13,220,000 and an EBITDA of -$13,473,000, indicating a severe disconnect between top-line generation and bottom-line profitability. This massive gap between the minimal revenue of $289,000 and the significant net loss of -$13,220,000 reveals a highly fragile cost structure where operating expenses vastly exceed all income sources, leading to a profit margin of 0.0%. The firm's gross margin stands at 0.7%, which implies that the cost of goods sold consumes nearly the entirety of its revenue before operating expenses are even calculated. Furthermore, the operating margin is reported at -4713.8%, a figure that underscores extreme inefficiency or one-time extraordinary charges that have decimated operational profitability relative to sales. Regarding liquidity and solvency, the company holds $3.16 million in cash against total debt of $480,000, resulting in a debt-to-equity ratio of 20.66. Despite the high leverage indicated by the debt-to-equity metric, the substantial cash reserve provides a buffer, though the negative free cash flow of -$5,668,375 suggests that cash generation is insufficient to cover operational burn rates. The current ratio is 1.56, indicating that the company possesses 1.56 dollars of current assets for every dollar of current liabilities, which points to a moderate level of short-term liquidity. Finally, the return on equity is -397.9% and the return on assets is -127.0%, metrics that reveal that management has failed to generate any positive returns on shareholder capital or total assets during the reporting period.

估值评估

Trailing P/E and forward P/E ratios are not available for Inspira Technologies Oxy B.H.N. Ltd., which is typical for companies reporting substantial losses as earnings per share becomes negative or undefined. The price-to-book ratio is recorded at 1.54, suggesting that the market values the company at a premium of 54% over its net book value, a metric that can be distorted when earnings are negative. Alternative valuation metrics such as price-to-sales and EV/EBITDA are also unavailable due to the lack of positive earnings or defined sales multiples in the current dataset. The stock's price action has exhibited extreme volatility, with a 52-week high of $0.80 and a 52-week low of $0.05. Relative to this trading range, the current market price sits significantly below the 52-week high, reflecting the investor sentiment associated with the company's negative earnings profile. The stock carries a beta of 2.33, which indicates that the share price is expected to be 133% more volatile than the broader market index, exposing investors to substantial fluctuations for every unit of market movement.

Growth & Income

Revenue growth year-over-year and earnings growth year-over-year are not available, preventing a direct comparison of whether earnings are growing faster or slower than revenue. Consequently, the company does not pay dividends, as evidenced by the absence of a dividend yield and payout ratio in the financial data. Since the firm does not distribute dividends, it is not generating distributable cash flow to shareholders, and instead, any theoretical earnings would need to be reinvested, though the current negative earnings preclude such reinvestment. The overall growth and income profile is characterized by a complete lack of historical growth data and an absence of income generation through dividends or earnings, positioning the asset purely as a speculative vehicle based on future development milestones rather than current financial performance.